Clinical Outcomes of Osteoarticular Extracorporeal Irradiated Autograft for Malignant Bone Tumor
Table 1
Patient characteristics.
No.
Site
Age (years)
Sex
Tumor
Follow-up (months)
Patient status
Reason for reoperation
Salvage procedure
Graft removal (months)
Radiographic evaluation (total (%))
MSTS (total (%))
Leg length discrepancy
1
Scapula glenoid
47
M
Bone met (clear cell sarcoma)
5
DOD
—
—
—
32 (100)
NA
—
2
Scapula glenoid
61
M
Osteosarcoma
81
CDF
—
—
—
31 (96.9)
NA
—
3
Scapula glenoid
40
M
Chondrosarcoma
52
CDF
Wire protrusion
Wire removal
—
31 (96.9)
25(83.3)
—
4
Proximal humerus
22
F
Osteosarcoma
55
CDF
—
—
—
27 (84.4)
23 (76.7)
—
5
Proximal humerus
6
F
Osteosarcoma
106
NED
Fracture
ORIF
—
9 (28.1)
19 (63.3)
—
6
Proximal humerus
12
F
Osteosarcoma
191
CDF
IM rod protrusion
IM rod removal
—
16 (50.0)
26 (86.7)
—
7
Proximal humerus
58
M
Osteosarcoma
264
CDF
Infection
Debridement of soft tissue
—
25 (78.1)
23 (76.7)
—
8
Proximal humerus
14
F
Osteosarcoma
256
CDF
—
—
—
18 (56.3)
NA
—
9
Proximal humerus
49
F
Bone met (thyroid)
252
AWD
Screw protrusion
Screw removal
—
16 (50.0)
22 (73.3)
—
10
Proximal humerus
17
F
Ewing sarcoma
172
CDF
—
—
—
17 (53.1)
18 (60.0)
—
11
Proximal humerus
18
M
Osteosarcoma
125
CDF
—
—
—
17 (53.1)
23 (76.7)
—
12
Distal humerus
8
M
Mesenchymal chondrosarcoma
192
CDF
Infection
Removal of ECIA, fibula graft
13
NA
NA
—
13
Distal humerus
13
F
Osteosarcoma
152
CDF
—
—
—
19 (59.4)
23 (76.7)
—
14
Proximal ulna
67
M
Synovial sarcoma
82
DOD
—
—
—
32 (100)
NA
—
15
Proximal radius
25
M
Liposarcoma
67
CDF
—
—
—
22 (68.8)
23 (76.7)
—
16
Distal radius
14
F
Osteosarcoma
252
CDF
—
—
—
17 (53.1)
18 (60.0)
—
17
Metacarpal
43
M
Clear cell sarcoma
47
DOD
—
—
—
18 (56.3)
NA
—
18
Acetabulum
15
M
Myxoid liposarcoma
41
DOD
—
—
—
29 (90.6)
NA
—
19
Acetabulum
11
F
Ewing sarcoma
75
NED
Infection
Debridement of soft tissue, muscle cutaneous flap
—
29 (90.6)
22 (73.3)
—
20
Acetabulum
64
M
Chondrosarcoma
220
DOD
Infection
Debridement of soft tissue
—
8 (25.0)
21 (70.0)
—
21
Proximal femur
21
F
Osteosarcoma
57
DOD
Infection
Debridement of soft tissue
—
19 (59.4)
NA
—
22
Distal femur
6
M
Osteosarcoma
129
CDF
—
—
—
26 (81.3)
24 (80.0)
36 mm
23
Distal femur
13
M
Osteosarcoma
256
CDF
—
—
—
27 (84.4)
28 (93.3)
57 mm
24
Distal femur
13
M
Osteosarcoma
264
NED
Infection
Removal of ECIA, endoprosthetic replacement
14
NA
NA
NA
25
Proximal tibia
9
M
Osteosarcoma
47
DOD
Infection
Removal of ECIA
9
NA
NA
NA
26
Proximal tibia
20
M
Osteosarcoma
258
CDF
Infection
Removal of ECIA, prosthetic composite TKA
25
18 (56.3)
NA
—
27
Proximal tibia
17
M
Osteosarcoma
207
CDF
Degenerative change
Removal of ECIA, prosthetic composite TKA
16
16 (50.0)
NA
—
28
Proximal tibia
17
M
Liposarcoma
214
CDF
Infection
Debridement of soft tissue
—
15 (46.9)
16 (53.3)
—
29
Proximal tibia
8
F
Ewing sarcoma
103
CDF
Screw protrusion
Screw removal
—
20 (62.5)
23 (76.7)
32 mm
30
Proximal tibia
10
F
Osteosarcoma
97
CDF
—
—
—
18 (56.3)
23 (76.7)
40 mm
31
Distal tibia
26
F
Low-grade central osteosarcoma
134
CDF
—
—
—
28 (87.5)
23 (76.7)
—
32
Distal tibia
40
M
Osteosarcoma
90
CDF
—
—
—
15 (46.9)
18 (60.0)
—
33
Distal tibia
13
F
Osteosarcoma
46
CDF
—
—
—
22 (68.8)
24 (80.0)
—
Functional score or leg discrepancy was not recorded due to death, graft removal, or lost to follow-up. Percutaneous epiphysiodesis using transphyseal screws of the contralateral distal femur and proximal tibia was performed.
